Swab and viral transport medium is a transport and collection system used for long-term freezing, transport, and collection of clinical specimens that contain viruses. The major categories of organisms often transported with such mediums include chlamydia, urea plasma organisms, and mycoplasma. With the outbreak of the COVID-19 pandemic, swab and viral transport mediums are being used to freeze and collect the SARS-CoV-19 virus samples. The swabs are rubbed against the skin or vesicles to collect samples of viruses. The collected samples are then sent to the laboratories in transport mediums.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
At the early phase of the COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global markets. These players achieved an edge over other diagnostics players capitalizing on the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
However, with COVID-19 the supply chain of the raw material required to manufacture swabs and viral transport medium has been disrupted in many countries. In addition, the market growth of diagnostic products is declining as the manufacturers of diagnostic kits have slowed down their production due to the pandemic. This, in turn, is expected to have a significant impact on the swab and viral transport medium market.
Top Impacting Factors
- The SARS-CoV-2 has had a positive impact on the swab and viral transport medium market, owing to rise in diagnostic tests for the virus taking place all over the world.
- The government is highly involved in the development activities for a novel swab and viral transport mediums, which boosted the swab and viral transport medium market.
- Surge in number of new viruses emerging that can cause various diseases in humans is an additional factor contributing to the growth of the swab and viral transport medium market.
- However, the supply chain of raw materials required to manufacture swabs and viral transport medium is not well developed in many developing nations. This can impede the growth of the swab and viral transport medium market.
Key Market Trends
- Key manufacturers in the swab and viral transport medium market are taking efforts to develop products that are in compliance with the stringent regulatory standards in many parts of the world.
- The integration of swabs that are polyester-based is projected to generate profitable opportunities in the market, owing to their faster manufacturing processes and lower production costs.
- Key players of the swab and viral transport medium market are ramping up their production capacities to meet the needs of the market.
- North America is expected to dominate the swab and viral transport medium market, due to the increasing number of viral diagnostic tests development and the presence of major market players in this region.
- The Asia-Pacific market for swab and viral transport medium is expected to show a huge growth rate during the forecast period, due to the rising demand for specimen collection kits.
Key Benefits of the Report
- This study presents the analytical depiction of the swab and viral transport medium industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the swab and viral transport medium market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.
Questions Answered in the Swab and Viral Transport Medium Report
- Which are the leading players active in the swab and viral transport medium market?
- How is each segment of the market expected to grow during the forecast period?
- What are the adoption trends for the swab and viral transport medium market in emerging economies and established economies across the world?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps in the market?
- What are the impacts of COVID-19 on the industry?
- What are swab and viral transport mediums?
- What are the current and predicted trends of the market?
Swab and Viral Transport Medium Market Report Highlights
| Aspects | Details |
 By Indication |
|
 By End User |
|
 By Region |
|
 Key Market Players | Becton, Dickinson And Company, Copan Diagnostics, Inc., MANTACC, Yocon Biology, Vircell S.L., Trinity Biotech,, Thermo Fisher Scientific Inc., MWE, Puritan Medical Products, Titan Biotech Ltd. |
Loading Table Of Content...
